More education linked to slow aging, reduced death risk, landmark study finds
By
Kristen Fischer
Mar 08, 2024
More school translated to a slower pace of aging — a measure that translates to a 10% lower risk of dying, according to a new study.
Parkinson’s breakthrough: Researchers find way to halt disease progression
By
Alicia Lasek
Jun 07, 2019
Japanese researchers have successfully reduced Parkinson’s-like symptoms in mice. The breakthrough could unearth preventive treatments, they said.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Study: Meditation supports well-being among those 60-plus
By
Kristen Fischer
Dec 04, 2023
Meditation can improve the well-being of older adults, according to findings published in PLOS ONE on Friday.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Gout guidance highlights treat-to-target drug therapy
By
Alicia Lasek
May 12, 2020
Experts strongly recommend moving away from a fixed-dose approach to urate lowering therapy in updated guidelines for 2020.
Long-term study links infections to 70 percent higher dementia risk
By
Alicia Lasek
Jan 10, 2023
A study with 32 years of followup has linked infections in hospitalized patients to future dementia onset. Urinary tract infections are among those with the strongest link.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Epilepsy raises risk of developing Alzheimer’s, and vice-versa
By
Alicia Lasek
May 29, 2023
People with a common type of epilepsy have nearly four times the relative odds of receiving an Alzheimer’s diagnosis, a new study finds.